home / stock / azyo / azyo news


AZYO News and Press, Aziyo Biologics Inc. From 05/19/23

Stock Information

Company Name: Aziyo Biologics Inc.
Stock Symbol: AZYO
Market: NASDAQ

Menu

AZYO AZYO Quote AZYO Short AZYO News AZYO Articles AZYO Message Board
Get AZYO Alerts

News, Short Squeeze, Breakout and More Instantly...

AZYO - Aziyo gains on data for wound healing product in cardiac implantation

2023-05-19 09:13:45 ET Aziyo Biologics ( NASDAQ: AZYO ) added ~8% pre-market Friday after announcing the study data supporting the potential of its healing product CanGaroo Biologics Envelope when with a cardiac implantable electronic device (CIED). The U.S.-based trial invo...

AZYO - Aziyo Biologics Presents Positive Clinical Data on CanGaroo® Biologic Envelope

Study Presented at Heart Rhythm Society Supports Wound-Healing Benefits in Patients Receiving Cardiac Implantable Electronic Devices SILVER SPRING, Md., May 19, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercialize...

AZYO - Aziyo Biologics, Inc. (AZYO) Q1 2023 Earnings Call Transcript

2023-05-14 21:32:09 ET Aziyo Biologics, Inc. (AZYO) Q1 2023 Earnings Conference Call May 10, 2023 16:30 ET Company Participants Matt Steinberg - Investor Relations Randy Mills - Chief Executive Officer Matt Ferguson - Chief Financial Officer Conference Call...

AZYO - Aziyo Biologics GAAP EPS of -$0.49 beats by $0.05, revenue of $13.1M misses by $0.6M

2023-05-10 16:14:49 ET Aziyo Biologics press release ( NASDAQ: AZYO ): Q1 GAAP EPS of -$0.49 beats by $0.05 . Revenue of $13.1M (+13.9% Y/Y) misses by $0.6M . Gross profit for the first quarter of 2023 was $6.3 million and gross margin was 49%, as compared to $...

AZYO - Aziyo Biologics Reports Highest Sales and Gross Profit in Company History

- All Four Business Segments Achieved Growth Led by Strong SimpliDerm and CanGaroo Sales - SILVER SPRING, Md., May 10, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes biologic products to improve compatibility...

AZYO - Aziyo Biologics to Report First Quarter 2023 Financial Results on Wednesday, May 10, 2023

SILVER SPRING, Md., May 03, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them, today announced that it will release its...

AZYO - EyePoint, Tenaya top healthcare gainers; Aditxt, Ocuphire among losers

2023-04-21 10:03:36 ET Gainers: EyePoint Pharmaceuticals ( EYPT ) +19% . Tenaya Therapeutics ( TNYA ) +21% . Community Health Systems ( CYH ) +11% . NovaBay Pharmaceuticals ( NBY ) +11% . Aziyo Biologics ( AZYO ) +8% . Loser...

AZYO - Aziyo Biologics and LeMaitre Vascular Partner for the Distribution of Aziyo's Cardiovascular Portfolio

SILVER SPRING, Md., April 20, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them, today announced it has entered into a ...

AZYO - ZyVersa, Aziyo top healthcare gainers; Cidara, Protagenic among losers

2023-03-23 10:06:23 ET Gainers: ZyVersa Therapeutics ( ZVSA ) +33% . Aziyo Biologics ( AZYO ) +29% . Generation Bio ( GBIO ) +20% . HTG Molecular Diagnostics ( HTGM ) +16% . scPharmaceuticals ( SCPH ) +15% . Losers:...

AZYO - Aziyo Biologics, Inc. (AZYO) Q4 2022 Earnings Call Transcript

2023-03-22 18:12:04 ET Aziyo Biologics, Inc. (AZYO) Q4 2022 Earnings Conference Call March 22, 2023, 04:30 PM ET Company Participants Matt Steinberg - Investor Relations, FINN Partners Randy Mills - Chief Executive Officer Matt Ferguson - Chief Financial Officer ...

Previous 10 Next 10